ArticleTherapeutic innovation & regulatory science2026
Adverse Events Associated with Clascoterone: A Real-World Pharmacovigilance Study of the Food and Drug Administration Adverse Event Reporting System.
Li Tao et al.PubMed ↗Publisher ↗
No numbers read from the abstract.